Pharmafile Logo
Pharmafocus logo
Advanced Search

BASILEA announces positive results of Phase IIII study into SAB treatment

June 28, 2022
Manufacturing and Production

Basilea Pharmaceutica has announced positive topline results for the Phase III ERADICATE study, evaluating ceftobiprole in the treatment of adult …

News

EMA grants Bavarian Nordic’s respiratory treatment access to priority medicines scheme

June 28, 2022
Manufacturing and Production

The EMA has granted access to its priority medicines (PRIME) scheme for MVA-BN RSV in the active immunisation for the …

News

Positive CHMP opinion for biosimilar for cancer treatment

June 28, 2022
Manufacturing and Production

The CHMP of the EMA has adopted a positive opinion for the marketing authorisation of a bevacizumab biosimilar candidate, Vegzelma. …

News

Telehealth clinics still offering abortion pills to people outside their states

June 27, 2022
Sales and Marketing

Telehealth abortion clinics have shared that they are still offering pills to people outside of their states, following the Supreme …

News

China NMPA approves TYVYT for gastric/gastroesophageal junction adenocarcinoma

June 27, 2022
Sales and Marketing

The National Medical Products Administration (NMPA) has approved the supplemental NDA for TYVYT (sintilimab injection) in combination with fluorouracil and …

News

NHS patients could have chance to travel for surgery

June 27, 2022
Sales and Marketing

NHS patients in England, who have been waiting over two years for surgery are being offered hospital treatment in certain …

News

CHMP recommends treatment for adults with chronic inflammatory disease

June 27, 2022
Sales and Marketing

The CHMP has recommended upadacitinib (RINVOQ® 15 mg, once daily) for approval, for the treatment of adults with active non-radiographic …

News

Polio virus detected in sewage from North and East London

June 22, 2022
Research and Development

Traces of the polio virus have been found during a routine sewage inspection in London. The UKHSA has consequently declared …

News

FDA grants Breakthrough Device Designation to pulmonary hypertension early detection AI

May 25, 2022
Research and Development

Anumana has announced the FDA had granted Breakthruogh Device Designation to its AI-enhanced ECG-based Pulmonary Hypertension (PH) Early Detection Algorithm. …

News

Clinical study of digital biomarker platform in degenerative neurological diseases

May 25, 2022
Research and Development

Cumulus Neuroscience has announced the start of two validation trials – CNS-101 and CNS-102 – supported by a group of …

News
mat-napo-pij34zrzeew-unsplash

WHO director warns ‘COVID-19 is not over’

May 25, 2022
Research and Development

Dr Tedros Adhanom Gebreyesus has delivered a message at the opening of the 75th World Health Assembly. He highlighted: “So, …

News

JCVI issues recommendations for booster jabs later this year

May 25, 2022
Research and Development

The JCVI has advised the government to provide an autumn COVID-19 booster programme in preparation for the winter. The recommendations …

News

First patient enrolled in melanoma study

May 24, 2022
Manufacturing and Production

Pierre Fabre and the European Organisation for Research and Treatment of Cancer (EORTC) have announced the screening of the first …

News

35 common health conditions GPs will no longer issue a prescription for

May 24, 2022
Manufacturing and Production

The NHS has published a list of 35 conditions that no longer require a prescription from a GP. These include …

News

131 confirmed cases of monkeypox reported in 19 countries

May 24, 2022
Manufacturing and Production

UK officials have warned that monkeypox could turn into a Europe-wide endemic if pets catch the virus. This could also …

News

Regeneron treatment fights ultra-rare form of high cholesterol in children

May 24, 2022
Manufacturing and Production

Regeneron has shared positive results from its Phase III trial of a candidate drug, for children with a rare, life-threatening …

News

Monkeypox outbreak in Europe: UK guidance recommends close contacts isolate for 21 days

May 23, 2022
Sales and Marketing

The UK Health Security Agency (UKHSA) has released updated guidance on monkeypox now recommending that those who have had “unprotected …

News

FDA grant orphan drug designation to XMT-2056 for treatment of gastric cancer

May 20, 2022
Medical Communications

Mersana Theapeutics has announced that the FDA has granted orphan drug designation to XMT-2056, the company’s lead Immunosynthen STING-agonist ADC, …

News

WHO says world still unprepared for future pandemics even after COVID-19

May 20, 2022
Medical Communications

An expert panel has said that the world is still not ready for future pandemics, despite having years to prepare …

News

Collaboration to boost access to cancer medicines in low- and middle-income countries

May 20, 2022
Medical Communications

Novartis, Roche, and other pharmaceutical companies have formed a coalition with global cancer organisations in an aim to get more …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026